Literature DB >> 15486690

Amino acid patterns within short consensus repeats define conserved duplicons shared by genes of the RCA complex.

Craig A McLure1, Roger L Dawkins, Joseph F Williamson, Richard A Davies, Jemma Berry, Longman-Jacobsen Natalie, Rebecca Laird, Silvana Gaudieri.   

Abstract

Complement control proteins (CCPs) contain repeated protein domains, short consensus repeats (SCRs), which must be relevant to diverse functions such as complement activation, coagulation, viral binding, fetal implantation, and self-nonself recognition. Although SCRs share some discontinuous and imperfect motifs, there are many variable positions and indels making classification in subfamilies extremely difficult. Using domain-by-domain phylogenetic analysis, we have found that most domains can be classified into only 11 subfamilies, designated a, b, c, d, e, f, g, h, i, j, or k and identified by critical residues. Each particular CCP is characterized by the order of representatives of the subfamilies. Human complement receptor 1 (CR1) has ajefbkd repeated four times and followed by ch. The classification crosses CCPs and indicates that a particular CCP is a function of the mix of SCRs. The aje set is a feature of several CCPs including human CR1 and DAF and murine Crry and appears to be associated with the success or failure of implantation inter alia. This approach facilitates genomic analysis of available sequences and suggests a framework for the evolution of CCPs. Units of duplication range from single SCRs, to septamers such as efbkdaj, to extensive segments such as MCP-CR1L. Imperfections of duplication with subsequent deletion have contributed to diversification.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15486690     DOI: 10.1007/s00239-004-2609-8

Source DB:  PubMed          Journal:  J Mol Evol        ISSN: 0022-2844            Impact factor:   2.395


  22 in total

1.  An integrated map of the human regulator of complement activation (RCA) gene cluster on 1q32.

Authors:  S Rodríguez de Córdoba; M A Díaz-Guillén; D Heine-Suñer
Journal:  Mol Immunol       Date:  1999 Sep-Oct       Impact factor: 4.407

Review 2.  Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1.

Authors:  D Hourcade; M K Liszewski; M Krych-Goldberg; J P Atkinson
Journal:  Immunopharmacology       Date:  2000-08

3.  Structure of complement receptor 2 in complex with its C3d ligand.

Authors:  G Szakonyi; J M Guthridge; D Li; K Young; V M Holers; X S Chen
Journal:  Science       Date:  2001-06-01       Impact factor: 47.728

Review 4.  The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function.

Authors:  V M Holers; T Kinoshita; H Molina
Journal:  Immunol Today       Date:  1992-06

5.  Large-scale search for genes on which positive selection may operate.

Authors:  T Endo; K Ikeo; T Gojobori
Journal:  Mol Biol Evol       Date:  1996-05       Impact factor: 16.240

Review 6.  Immunomodulatory functions of murine CR1/2.

Authors:  J Prechl; A Erdei
Journal:  Immunopharmacology       Date:  2000-08

7.  Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases.

Authors:  M Krych-Goldberg; R E Hauhart; V B Subramanian; B M Yurcisin; D L Crimmins; D E Hourcade; J P Atkinson
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

8.  Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome.

Authors:  R Schwarzenbacher; K Zeth; K Diederichs; A Gries; G M Kostner; P Laggner; R Prassl
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

9.  Structure-function analysis of the active sites of complement receptor type 1.

Authors:  M Krych; R Hauhart; J P Atkinson
Journal:  J Biol Chem       Date:  1998-04-10       Impact factor: 5.157

Review 10.  Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease.

Authors:  R Dawkins; C Leelayuwat; S Gaudieri; G Tay; J Hui; S Cattley; P Martinez; J Kulski
Journal:  Immunol Rev       Date:  1999-02       Impact factor: 12.988

View more
  4 in total

1.  Extensive genomic and functional polymorphism of the complement control proteins.

Authors:  Craig A McLure; Joseph F Williamson; Louise A Smyth; Suraksha Agrawal; Susan Lester; John A Millman; Peter J Keating; Brent J Stewart; Roger L Dawkins
Journal:  Immunogenetics       Date:  2005-11-11       Impact factor: 2.846

2.  Genomic analysis reveals a duplication of eight rather than seven short consensus repeats in primate CR1 and CR1L: evidence for an additional set shared between CR1 and CR2.

Authors:  C A McLure; J F Williamson; B J Stewart; P J Keating; R L Dawkins
Journal:  Immunogenetics       Date:  2004-10-30       Impact factor: 2.846

3.  Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites.

Authors:  N Brouwers; C Van Cauwenberghe; S Engelborghs; J-C Lambert; K Bettens; N Le Bastard; F Pasquier; A Gil Montoya; K Peeters; M Mattheijssens; R Vandenberghe; P P De Deyn; M Cruts; P Amouyel; K Sleegers; C Van Broeckhoven
Journal:  Mol Psychiatry       Date:  2011-03-15       Impact factor: 15.992

4.  Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode.

Authors:  Federico Forneris; Jin Wu; Xiaoguang Xue; Daniel Ricklin; Zhuoer Lin; Georgia Sfyroera; Apostolia Tzekou; Elena Volokhina; Joke Cm Granneman; Richard Hauhart; Paula Bertram; M Kathryn Liszewski; John P Atkinson; John D Lambris; Piet Gros
Journal:  EMBO J       Date:  2016-03-24       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.